Anti-diabetic effect of Alpinia oxyphylla extract on 57BL/KsJ db-/db- mice

Experimental and Therapeutic Medicine

Volumn 13, Issue 4, 2017, Pages 1321-1328

  Xie, Yiqiang ^a   Xiao, Man ^a   Li, Dan ^a   Liu, Hongqin ^a   Yun, Fenglin ^a   Wei, Yi ^a   Sang, Shenggang ^a   Du, Guankui ^a  

^a HAINAN MEDICAL UNIVERSITY   (China)

Author keywords

Alpinia oxyphylla extract; Db db mice; Hyperglycemia; Oxidative stress; Phosphatase and tensin homolog

Indexed keywords

ALBUMIN; ALPINIA OXYPHYLLA EXTRACT; ANTIOXIDANT; CREATININE; GLUCOSE; GLUTATHIONE; INSULIN; MALONALDEHYDE; PEROXIDASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PLACEBO; PLANT EXTRACT; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALPINIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DB/DB MOUSE; DIABETIC NEPHROPATHY; DPPH RADICAL SCAVENGING ASSAY; DYSLIPIDEMIA; GENE EXPRESSION REGULATION; HYPERGLYCEMIA; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PROTEIN EXPRESSION; UPREGULATION; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING;

EID: 85013818819     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2017.4152     Document Type: Article

References (44)

1. Dunkley AJ, Bodicoat DH, Greaves CJ, Russell C, Yates T, Davies MJ and Khunti K: Diabetes prevention in the real world: Effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: A systematic review and Meta-analysis. Diabetes Care 37: 922-933, 2014.
2. Liakos A, Karagiannis T, Athanasiadou E, Sarigianni M, Mainou M, Papatheodorou K, Bekiari E and Tsapas A: Efficacy and safety of empagliflozin for type 2 diabetes: A systematic review and meta-analysis. Diabetes Obes Metab 16: 984-993, 2014.
3. da Rocha Fernandes J, Ogurtsova K, Linnenkamp U, Guariguata L, Seuring T, Zhang P, Cavan D and Makaroff LE: IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes. Diabetes Res Clin Pract 117: 48-54, 2016.
4. Nowotny K, Jung T, Hohn A, Weber D and Grune T: Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules 5: 194-222, 2015.
5. Abdali D, Samson SE and Grover AK: How effective are antioxidant supplements in obesity and diabetes? Med Princ Pract 24: 201-215, 2015.
6. Gurzov EN, Tran M, Fernandez-Rojo MA, Merry TL, Zhang X, Xu Y, Fukushima A, Waters MJ, Watt MJ, Andrikopoulos S, et al: Hepatic oxidative stress promotes insulin-STAT-5 signaling and obesity by inactivating protein tyrosine phosphatase N2. Cell Metab 20: 85-102, 2014.
7. Wang X, Zhang W, Chen H, Liao N, Wang Z, Zhang X and Hai C: High selenium impairs hepatic insulin sensitivity through opposite regulation of ROS. Toxicol Lett 224: 16-23, 2014.
8. Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, Neumiller JJ, Nwankwo R, Verdi CL, Urbanski P and Yancy WS Jr: Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 37 (Suppl 1): S120-S143, 2014.
9. Afolayan AJ and Wintola OA: Dietary supplements in the management of hypertension and diabetes-a review. Afr J Tradit Complement Altern Med 11: 248-258, 2014.
10. Patel D, Kumar R, Laloo D and Hemalatha S: Natural medicines from plant source used for therapy of diabetes mellitus: An overview of its pharmacological aspects. Asian Pacific Journal of Tropical Disease 2: 239-250, 2012.
11. Commission CP (ed): Pharmacopoeia of the People's Republic of China, vol.1. China Medical Science and Technology Press, Beijing, 2010.
12. -42 mouse model of Alzheimer's disease. Int Immunopharmacol 23: 719-725, 2014.
13. Chen J, Wang D and Chen W: Application on Alpinia oxyphylla extraction as food preservative on mango. Food Sci Technol 4: 309-314, 2015 (In Chinese).
14. Qing ZJ, Yong W, Hui LY, Yong LW, Long LH, Ao DJ and Xia PL: Two new natural products from the fruits of Alpinia oxyphylla with inhibitory effects on nitric oxide production in lipopolysaccharide-activated RAW264.7 macrophage cells. Arch Pharm Res 35: 2143-2146, 2012.
15. Butler M, McKay RA, Popoff IJ, Gaarde WA, Witchell D, Murray SF, Dean NM, Bhanot S and Monia BP: Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice. Diabetes 51: 1028-1034, 2002.
16. Nakashima N, Sharma PM, Imamura T, Bookstein R and Olefsky JM: The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes. J Biol Chem 275: 12889-12895, 2000.
17. Wang CZ, Yuan HH, Bao XL and Lan MB: In vitro antioxidant and cytotoxic properties of ethanol extract of Alpinia oxyphylla fruits. Pharm Biol 51: 1419-1425, 2013.
18. Lott JA and Turner K: Evaluation of Trinder's glucose oxidase method for measuring glucose in serum and urine. Clin Chem 21: 1754-1760, 1975.
19. Fossati P and Prencipe L: Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28: 2077-2080, 1982.
20. Richmond W: Preparation and properties of a cholesterol oxidase from Nocardia sp. And its application to the enzymatic assay of total cholesterol in serum. Clin Chem 19: 1350-1356, 1973.
21. Janero DR: Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 9: 515-540, 1990.
22. Beauchamp C and Fridovich I: Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels. Anal Biochem 44: 276-287, 1971.
23. Fossati P, Prencipe L and Berti G: Enzymic creatinine assay: A new colorimetric method based on hydrogen peroxide measurement. Clin Chem 29: 1494-1496, 1983.
24. Foster LB and Hochholzer JM: A single-reagent manual method for directly determining urea nitrogen in serum. Clin Chem 17: 921-925, 1971.
25. Dinis TC, Maderia VM and Almeida LM: Action of phenolic derivatives (acetaminophen, salicylate, and 5-aminosalicylate) as inhibitors of membrane lipid peroxidation and as peroxyl radical scavengers. Arch Biochem Biophys 315: 161-169, 1994.
26. Du Toit R, Volsteedt Y and Apostolides Z: Comparison of the antioxidant content of fruits, vegetables and teas measured as vitamin C equivalents. Toxicology 166: 63-69, 2001.
27. Miao Q, Kong W, Zhao X, Yang S and Yang M: GC-FID coupled with chemometrics for quantitative and chemical fingerprinting analysis of Alpinia oxyphylla oil. J Pharm Biomed Anal 102: 436-442, 2015.
28. β-induced cognitive impairment and neuronal abnormalities in the cortex and hippocampus of mice. Oxid Med Cell Longev 2014: 451802, 2014.
29. Shi SH, Zhao X, Liu AJ, Liu B, Li H, Wu B, Bi KS and Jia Y: Protective effect of n-butanol extract from Alpinia oxyphylla on learning and memory impairments. Physiol Behav 139: 13-20, 2015.
30. Surh Y: Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat Res 428: 305-327, 1999.
31. Lin RJ, Yen CM, Chou TH, Chiang FY, Wang GH, Tseng YP, Wang L, Huang TW, Wang HC, Chan LP, et al: Antioxidant, anti-adipocyte differentiation, antitumor activity and anthelmintic activities against Anisakis simplex and Hymenolepis nana of yakuchinone A from Alpinia oxyphylla. BMC Complement Altern Med 13: 237, 2013.
32. Bian QY, Wang SY, Xu LJ, Chan CO, Mok DK and Chen SB: Two new antioxidant diarylheptanoids from the fruits of Alpinia oxyphylla. J Asian Nat Prod Res 15: 1094-1099, 2013.
33. Xu J, Ji C, Zhang Y, Su J, Li Y and Tan N: Inhibitory activity of eudesmane sesquiterpenes from Alpinia oxyphylla on production of nitric oxide. Bioorg Med Chem Lett 22: 1660-1663, 2012.
34. Shui Guan, Bao YM, Bo Jiang and An LJ: Protective effect of protocatechuic acid from Alpinia oxyphylla on hydrogen peroxide-induced oxidative PC12 cell death. Eur J Pharmacol 538: 73-79, 2006.
35. Wang CZ, Yuan HH, Bao XL and Lan MB: In vitro antioxidant and cytotoxic properties of ethanol extract of Alpinia oxyphylla fruits. Pharm Biol 51: 1419-1425, 2013.
36. Ihara Y, Toyokuni S, Uchida K, Odaka H, Tanaka T, Ikeda H, Hiai H, Seino Y and Yamada Y: Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes 48: 927-932, 1999.
37. Szendroedi J, Phielix E and Roden M: The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 8: 92-103, 2011.
38. β-cell function and insulin resistance in overweight Chinese adolescents with normal glucose tolerance. Exp Ther Med 6: 547-551, 2013.
39. Huang B, Wang Z, Park JH, Ryu OH, Choi MK, Lee JY, Kang YH and Lim SS: Anti-diabetic effect of purple corn extract on C57BL/KsJ db-/db- mice. Nutr Res Pract 9: 22-29, 2015.
40. Parving HH, Oxenbøll B, Svendsen PA, Christiansen JS and Andersen AR: Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study ofurinary albumin excretion. Acta Endocrinol (Copenh) 100: 550-555, 1982.
41. Elks CM, Mariappan N, Haque M, Guggilam A, Majid DS and Francis J: Chronic NF-(kappa)B blockade reduces cytosolic and mitochondrial oxidative stress and attenuates renal injury and hypertension in SHR. Am J Physiol Renal Physiol 296: F298-F305, 2009.
42. Banday AA and Lokhandwala MF: Transcription factor Nrf2 protects renal dopamine D1 receptor function during oxidative stress. Hypertension 62: 512-517, 2013.
43. Chang CJ, Mulholland DJ, Valamehr B, Mosessian S, Sellers WR and Wu H: PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression. Mol Cell Biol 28: 3281-3289, 2008.
44. Birnbaum Y, Nanhwan MK, Ling S, Perez-Polo JR, Ye Y and Bajaj M: PTEN upregulation may explain the development of insulin resistance and type 2 diabetes with high dose statins. Cardiovasc Drugs Ther 28: 447-457, 2014.